Akin Gump Health and Policy Team Members Author Article on Federal Health Care MedTech Trends to Watch for in 2020

March 3, 2020

Reading Time : 1 min

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Scott Wasserman

Senior Media Relations Manager

Thomson Reuters Westlaw has published “MedTech update 2020 — Legal and regulatory issues to watch for in the medical technology industry in the new year: Federal health care programs,” an article by Akin Gump senior counsel Taylor Jones, senior policy advisor Heide Bajnrauh and counsel Eli Tomar. The article looks at some of the “significant legal, regulatory and market changes” that could have “a lasting impact” on medical device and diagnostics companies and laboratories this year with regard to federal health programs.

Originally included as part of a longer Akin Gump client alert issued in January, this article outlines several areas to watch for throughout the year. They include:

  • An expected decision by the Department of Health and Human Services to issue final value-based rules.
  • Clarification of the Sunshine Act requirements for medical devices.
  • Code changes that will go into effect.

 

To read the article in its entirety, please click here.

Share This Insight

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.